mourad drug corp.

283 commack road
commack, new york 11725

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 19, 2014

NYS DOS ID#
4579056

County
SCHOHARIE

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - MOURAD DRUG CORP.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Marine Corps Plane Crash: The Victims
    By THE NEW YORK TIMES - Thursday Jul 13, 2017

    Family members and friends have begun identifying many of the 16 American service members who died on Monday when their plane crashed in rural Mississippi.

    Source: NYT > Home Page
  • Rivoli Group AG Under New Management
    By Business Wire - Monday Jul 3, 2017

    Mourad Malloul takes over the management of the Swiss investment group, Rivoli Group AG. He was unanimously appointed president of the Group in a resolution of the general meeting of 3 May 2017. Mourad Malloul, the new president, will...

    Source: VentureBeat
  • Could the Rockaways Survive Another Sandy?
    By LUIS FERRÉ-SADURNÍ - Thursday Jul 13, 2017

    Residents are bracing for the worst, wondering whether measures taken so far are enough to keep devastation of the Queens community at bay.

    Source: NYT > Home Page
  • Most hated man in US soccer accused of ties to drug kingpin
    By Brian Lewis, Kaja Whitehouse - Wednesday Aug 9, 2017

    Rafael “Rafa” Marquez – who played for the NY Red Bulls before becoming captain of Mexico’s National Team – has been secretly acting as a frontman for a Mexican drug kingpin, according to the US Treasury Dept. Marquez, 37, is one of close to two dozen people the Treasury Dept. on Wednesday said has been helping hide...

    Source: New York Post: Sports
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
  • Billionaires, Bruised Egos, and the Death of a Grand Project
    By CHARLES V. BAGLI and ROBIN POGREBIN - Sunday Sep 24, 2017

    Barry Diller was about to win the battle for his $250 million arts pier, but then came the “petty questions” from his opponents and he decided to pull the plug.

    Source: NYT > Home Page